Anavo Therapeutics Appoints Dr. Vincent G. Brichard as Chairman of the Board

LEIDEN, Netherlands--(BUSINESS WIRE)--Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of phosphatase biology, today announced the appointment of Vincent G. Brichard, M.D., Ph.D., as Chairman of its Board of Directors. Dr. Brichard brings nearly four decades of experience from across the life sciences including groundbreaking biomedical research, drug development, venture capital investment and corporate strategy and transactions. His appointment marks an importan